IncubatorOne-stop business services for startups and foreign enterprises.
Dealroom labels its Chengdu profile as a China metro-area view with a stated population of 16 million. Its view reports 401 tracked startups and $410.2 million in venture capital invested.
Dealroom labels its Chengdu profile as a China metro-area view with a stated population of 16 million. Its view reports 401 tracked startups and $410.2 million in venture capital invested.
Tianhu Tech’s inventory records 167 Chengdu technology-startup financing events in the first half of 2025, including 49 in electronics and information, 39 in the digital economy, and 27 in healthcare. Chengdu High-Tech Zone accounted for 96 events, or 57.8% of the recorded total.
Startup ecosystem standing
| Ranking | Edition | Position | Since last edition | Trust | What it measures |
|---|---|---|---|---|---|
| 2026 | #20 | Up 4 | B | Innovation, Research, Activity | |
| GFCI 40 | #34 | Up 3 | B | Finance, Competitiveness, Business Climate | |
| 2025 | #103 | No prior edition | B | Ecosystem, Activity, Finance, Business Climate | |
| 2026 | 31 to 40 | No prior edition | C | Ecosystem, Performance, Finance, Talent |
4 organizations with a profile
IncubatorOne-stop business services for startups and foreign enterprises.
IncubatorEmpowering startups through incubation and expert guidance.
AcceleratorAccelerating global technology innovation.
InvestorSupporting China's emerging entrepreneurs.
Pick what describes you
Investors based here, and the programs that take teams at your stage.
Get investor introsAccelerators and incubators here see the earliest teams first.
Campuses and communities are where teams form before anyone funds them.
From public sources
The 2026 Chengdu science-project call had seven program categories, required lead units to be registered in Chengdu, and set an October 24, 2025 application deadline; this specific call is historical.
Source: Chengdu Municipal Science and Technology Bureau notice on the first batch of 2026 Chengdu science projectsMAXVAX reports RMB 200 million convertible-bond financing in January 2025.
Source: Milestones & honorsMAXVAX reports beginning Phase I/II trials of its recombinant RSV vaccine in November 2024.
Source: Milestones & honorsMAXVAX reports completing Series C funding of RMB 300 million in February 2024 and Series C+ funding of RMB 300 million in June 2024.
Source: Milestones & honorsMAXVAX reports that its RSV vaccine was accepted for IND by China's CDE in June 2024.
Source: Milestones & honorsMAXVAX reports that it was founded by Dr. Dexiang Chen in Chengdu in April 2016.
Source: Milestones & honorsChengdu is #103 of 1,473 in StartupBlink Index (cities) (2025). It appears in 4 published rankings; the table above lists each one.
1 investor based in Chengdu has a profile here: NewMargin Ventures. The real number is higher.
Yes. Chengdu has 1 accelerator and 2 incubators on record, including Sinic Innovation Accelerator and Greater Philadelphia (China) Investment Cooperation.
3 universities have a profile: Sichuan University, University of Electronic Science and Technology of China and Southwest Jiaotong University.
Superscout Pro
Is this page right?How the research works